MARIA IRAMA VILLAR GOMEZ-rekin lankidetzan egindako argitalpenak (12)

2020

  1. Ankle-brachial index and arterial vascular events in systemic lupus erythematosus patients: A 5-year prospective cohort

    Clinical and Experimental Rheumatology, Vol. 38, Núm. 5, pp. 978-984

2017

  1. Predictors of peripheral arterial disease in SLE change with patient's age

    Lupus Science and Medicine, Vol. 4, Núm. 1

2016

  1. LDLR and PCSK9 are associated with the presence of antiphospholipid antibodies and the development of thrombosis in aPLA carriers

    PLoS ONE, Vol. 11, Núm. 1

2015

  1. Prevalence and significance of persistently positive antiphospholipid antibodies in women with preeclampsia

    Journal of Rheumatology, Vol. 42, Núm. 2, pp. 210-213

2014

  1. Dr. Erdozain, et al reply

    Journal of Rheumatology

  2. Peripheral arterial disease in systemic lupus erythematosus: Prevalence and risk factors

    Journal of Rheumatology, Vol. 41, Núm. 2, pp. 310-317

  3. Prednisone in lupus nephritis: How much is enough?

    Autoimmunity Reviews, Vol. 13, Núm. 2, pp. 206-214

2013

  1. Pulmonary hypertension in systemic lupus erythematosus: Prevalence, predictors and diagnostic strategy

    Autoimmunity Reviews, Vol. 12, Núm. 3, pp. 410-415

2012

  1. Manejo del embarazo en pacientes con lupus eritematoso sistémico

    Revista Clinica Espanola, Vol. 212, Núm. 10, pp. 491-498

2007

  1. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus

    Lupus, Vol. 16, Núm. 10, pp. 810-816

2006

  1. Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus

    Lupus, Vol. 15, Núm. 9, pp. 577-583

  2. Tratamiento del síndrome antifosfolipídico en el embarazo

    Seminarios de la Fundacion Espanola de Reumatologia, Vol. 7, Núm. 2, pp. 59-69